Influenza – Monitoring Vaccine Effectiveness in Europe on COVID

Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic

Many partners, already involved in studies within the I-MOVE (Influenza - Monitoring Vaccine Effectiveness in Europe) network, came together as the I-MOVE-COVID-19 consortium. The consortium aims to obtain epidemiological and clinical information on patients with COVID-19 as well as virological information on SARS-CoV-2. 

The I-MOVE-COVID-19 project started on 1 April 2020.

RIVM colleague involved: Wim van der Hoek.


This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003673.